DUBLIN, IRELAND--(Marketwire - November 12, 2008) - Trinity Biotech plc (NASDAQ: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced it has engaged William Blair International, Limited in connection with the Company’s ongoing process to explore strategic alternatives to enhance shareholder value.
